feed,title,long_url,short_url
Benzinga,Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs,https://benzinga.com/analyst-ratings/analyst-color/24/07/39696693/johnson-johnson-faces-medtech-challenges-but-is-on-track-to-meet-2024-guidance-gold,https://da.gd/ph29I
